Safety and efficacy of bivalirudin for percutaneous coronary intervention with rotational atherectomy

Journal of Interventional Cardiology

Volumn 23, Issue 3, 2010, Pages 223-229

  Delhaye, Cedric ^a   Wakabayashi, Kohei ^a   Maluenda, Gabriel ^a   Ben Dor, Itsik ^a   Torguson, Rebecca ^a   Xue, Zhenyi ^a   Suddath, William O ^a   Satler, Lowell F ^a   Pichard, Augusto D ^a   Kent, Kenneth M ^a   Lindsay, Joseph ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; TICLOPIDINE;

ACUTE CORONARY SYNDROME; ANTICOAGULATION; ARTICLE; BLOOD TRANSFUSION; BODY MASS; BRAIN HEMORRHAGE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEATH; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HEMATOCRIT; HUMAN; HYPERTENSION; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; Q WAVE; RISK ASSESSMENT; ROTATIONAL ATHERECTOMY; VASCULAR DISEASE;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ANTICOAGULANTS; ATHERECTOMY, CORONARY; BODY MASS INDEX; COHORT STUDIES; CONFIDENCE INTERVALS; CORONARY ARTERY DISEASE; DISTRICT OF COLUMBIA; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMATOCRIT; HEPARIN; HIRUDINS; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO; PEPTIDE FRAGMENTS; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROPENSITY SCORE; RECOMBINANT PROTEINS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; STENTS;

EID: 77953192495     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2010.00546.x     Document Type: Article

References (17)

1. Cavusoglu E, Kini AS, Marmur JD, et al. Current status of rotational atherectomy. Catheter Cardiovasc Interv 2004 62 : 485 498.
2. Anderson HV, Shaw RE, Brindis RG, et al. A contemporary overview of percutaneous coronary interventions. The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). J Am Coll Cardiol 2002 39 : 1096 1103.
3. Madan P, Elayda MA, Lee VV, et al. Predicting major adverse cardiac events after percutaneous coronary intervention: The Texas Heart Institute risk score. Am Heart J 2008 155 : 1068 1074.
4. Manoukian SV, Feit F, Mehran R, et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: An analysis from the ACUITY Trial. J Am Coll Cardiol 2007 49 : 1362 1368.
5. Blankenship JC, Hellkamp AS, Aguirre FV, et al. Vascular access site complications after percutaneous coronary intervention with abciximab in the Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) trial. Am J Cardiol 1998 81 : 36 40.
6. Feit F, Voeltz MD, Attubato MJ, et al. Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial. Am J Cardiol 2007 100 : 1364 1369.
7. Watt J, Oldroyd KG. Radial versus femoral approach for high-speed rotational atherectomy. Catheter Cardiovasc Interv 2009 74 : 550 554.
8. Kini A, Reich D, Marmur JD, et al. Reduction in periprocedural enzyme elevation by abciximab after rotational atherectomy of type B2 lesions: Results of the Rota ReoPro randomized trial. Am Heart J 2001 142 : 965 969.
9. Kereiakes DJ. Preferential benefit of platelet glycoprotein IIb/IIIa receptor blockade: Specific considerations by device and disease state. Am J Cardiol 1998 81 (7A 49E 54E.
10. Lincoff AM, Bittl JA, Harrington RA, et al. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA 2003 289 : 853 863.
11. Stone GW, McLaurin BT, Cox DA, et al. Bivalirudin for patients with acute coronary syndromes. N Engl J Med 2006 355 : 2203 2216.
12. Stone GW, Witzenbichler B, Guagliumi G, et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 2008 358 : 2218 2230.
13. Kastrati A, Neumann FJ, Mehilli J, et al. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention. N Engl J Med 2008 359 : 688 696.
14. Gurm HS, Rajagopal V, Bhatt DL, et al. The safety of a bivalirudin-based approach in patients undergoing rotational atherectomy. J Invasive Cardiol 2007 19 : 225 228.
15. ANGIOMAX Prescribing Information. The Medicines Company; Parsippany NJ, December 6, 2005.
16. Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007 115 : 2344 2351.
17. Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987 76 : 142 154.